Vanguard Group’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $347K | Buy |
|
|||||
|
2025
Q1 | $924K | Sell |
|
|||||
|
2024
Q4 | $1.11M | Hold |
|
|||||
|
2024
Q3 | $2.14M | Hold |
|
|||||
|
2024
Q2 | $1.91M | Sell |
|
|||||
|
2024
Q1 | $2.21M | Sell |
|
|||||
|
2023
Q4 | $2M | Buy |
|
|||||
|
2023
Q3 | $5.92M | Buy |
|
|||||
|
2023
Q2 | $9.15M | Sell |
|
|||||
|
2023
Q1 | $11.7M | Buy |
|
|||||
|
2022
Q4 | $15.1M | Buy |
|
|||||
|
2022
Q3 | $23M | Buy |
|
|||||
|
2022
Q2 | $7.99M | Sell |
|
|||||
|
2022
Q1 | $18.1M | Sell |
|
|||||
|
2021
Q4 | $36.1M | Sell |
|
|||||
|
2021
Q3 | $70M | Buy |
|
|||||
|
2021
Q2 | $46.4M | Buy |
|
|||||
|
2021
Q1 | $51.1M | Buy |
|
|||||
|
2020
Q4 | $54.2M | Buy |
|
|||||
|
2020
Q3 | $37.3M | Buy |
|